The use of artificial intelligence in medicine is accelerating rapidly, and large companies — from Google, to Amazon, to Microsoft — are dedicating huge sums to developing novel products that offer big rewards, and equally large risks.

The Food and Drug Administration has already approved three products this year that use AI to help diagnose health problems, including one Thursday that detects wrist fractures. And some companies, like IBM, have put their products on the market without agency signoff.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy